The acetylase activity of p300 is dispensable for MDM2 stabilization

Area of Science:

• Molecular Biology
• Cancer Research
• Protein Biochemistry

Background:

• p300 is known to bind MDM2, a protein that regulates p53 function.
• The precise mechanism by which p300 influences MDM2 stability, particularly the role of its enzymatic activity, is not fully understood.

Purpose of the Study:

• To investigate whether the acetylase activity of p300 is essential for regulating MDM2 protein stability.
• To elucidate the mechanism underlying p300-mediated regulation of MDM2 levels.

Main Methods:

• In vitro and in-cell assays to assess p300's acetylation of MDM2.
• Western blotting to quantify MDM2 protein and mRNA levels following p300 overexpression.
• Analysis of MDM2 protein half-life in the presence of p300 and deacetylase inhibitors.
• Immunofluorescence microscopy to examine the localization of p300 and MDM2.

Main Results:

• p300 does not directly acetylate MDM2.
• Overexpression of p300, including an acetylase-defective mutant, increases MDM2 protein levels without affecting mRNA.
• p300 enhances the half-life of MDM2, while deacetylase inhibitors show no significant effect.
• Both wild-type and mutant p300 proteins co-localize with MDM2 in nuclear structures.

Conclusions:

• p300 stabilizes MDM2 protein by sequestering it within specific nuclear structures, protecting it from proteasomal degradation.
• The stabilization of MDM2 by p300 is independent of p300's acetylase activity.
• This mechanism offers a novel perspective on the regulation of the p53-MDM2 pathway.